US Patent 11773168 FcRn antibodies and methods of use thereof
Patent 11773168 was granted and assigned to Momenta Pharmaceuticals on October, 2023 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
December 13, 2018
Date of Patent
October 3, 2023
Patent Applicant
Patent Application Number
16771147
Patent Inventor Names
Darrell Nix
Nicholas A. Cilfone
Leona E. Ling
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11773168 FcRn antibodies and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
